Extensive pulmonary embolism associated with lupus anticoagulant

Area of Science:

• Cardiology
• Rheumatology
• Hematology

Background:

• Pulmonary embolism (PE) is a significant cause of morbidity and mortality.
• Lupus anticoagulant (LA) is an antiphospholipid antibody associated with an increased risk of thrombosis.
• Antiphospholipid syndrome (APS) encompasses recurrent thrombotic events in the presence of antiphospholipid antibodies.

Observation:

• A female patient presented with extensive pulmonary emboli.
• The patient was diagnosed with lupus anticoagulant.
• The clinical presentation indicated a severe thrombotic event.

Findings:

• Heparin treatment was initiated for the pulmonary emboli.
• The patient demonstrated a positive clinical response to heparin therapy.
• The case illustrates the efficacy of anticoagulation in managing PE associated with LA.

Implications:

• This case underscores the importance of early diagnosis and prompt anticoagulation in patients with PE and LA.
• Effective management with heparin can lead to favorable outcomes, even in cases of extensive disease.
• Further research into optimal anticoagulation strategies for APS-related thrombosis is warranted.